巴西的先进治疗产品:监管方面
João Batista Silva Junior1,2,3, Renata Miranda Parca4,5, Adriana Bastos Carvalho5,6
1Department of Pharmaceutical Sciences, College of Health Sciences, University of Brasilia, Brasilia, Brazil. batista.junior@anvisa.gov.br.
Advances in experimental medicine and biology
|August 1, 2023
概括
先进疗法产品,包括基因和细胞疗法,需要在巴西获得特别的Anvisa批准. 优化的监管途径确保安全,有效和高质量的治疗,特别是对于罕见疾病.
科学领域:
- 生物技术是生物技术.
- 监管科学 监管科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 先进疗法产品 (ATP) 包括复杂的生物制品,如基因,细胞和组织工程产品.
- 这些创新疗法在开发,风险评估和生命周期管理方面存在独特的挑战.
- 监管监督对于确保ATP的安全性,有效性和质量至关重要.
研究的目的:
- 概述巴西Anvisa批准先进治疗产品的监管框架.
- 强调科学证据和监管合规对于临床试验和产品批准的重要性.
- 描述适应性监管策略,以促进获取新型疗法,特别是罕见疾病.
主要方法:
- 审查有关先进治疗产品的Anvisa法规和指南.
- 对监管途径的分析,包括加速评估和紧急使用条款.
- 检查临床试验,益处风险评估和质量属性定义的要求.
- 讨论营销后监测,包括长期跟踪和药物监测.
主要成果:
- 巴西对ATP采用了优化的监管道,平衡创新与风险管理.
- 批准模型是根据技术特点和患者群体量身定制的,允许加快审查.
- 对于紧急情况和缺乏替代治疗方法的罕见疾病有特殊规定.
- 强有力的监测,包括长期安全/有效性跟踪和可追溯性,是监管过程中不可或缺的组成部分.
结论:
- 安维萨的监管方法促进了安全,有效和高质量的先进治疗产品的可用性.
- 适应性监管要素和药物监管是管理这些复杂药物的生命周期的关键.
- 确保患者及时获得创新疗法,同时保持严格的标准至关重要.
相关概念视频
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:26Drug Administration and Therapy Phases: Overview
540
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
540
01:03Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:28Global Regulatory Systems
44
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
44